Basics BioXcel Therapeutics, Inc. IPO Date: March 5, 2018 Sector: Healthcare Industry: Biotech Market Cap: $43.22M Activated in VL: True Average Daily Range Avg Daily Range: $0.61 | 4.26% Avg Daily Range (30 D): $0.12 | 4.19% Avg Daily Range (90 D): $0.22 | 6.79% Institutional Daily Volume Avg Daily Volume: .92M Avg Daily Volume (30 D): 1.26M Avg Daily Volume (90 D): 5.91M Trade Size Avg Trade Size (Sh.): 137 Avg Trade Size (Sh.) (30 D): 212 Avg Trade Size (Sh.) (90 D): 197 Institutional Trades Total Inst.Trades: 908 Avg Inst. Trade: $1.45M Avg Inst. Trade (30 D): $.87M Avg Inst. Trade (90 D): $.74M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.56M Avg Closing Trade (30 D): $.87M Avg Closing Trade (90 D): $.69M Avg Closing Volume: 4.6K     News Oct 13, 2025 @ 11:00 AM BioXcel Therapeutics to Ring Nasdaq Closing Bell o... Source: Vimal Mehta, Ph.D. Sep 18, 2025 @ 11:00 AM BioXcel Therapeutics Regains Compliance with Nasda... Source: Bioxcel Therapeutics, Inc. Aug 27, 2025 @ 12:00 PM UPDATE -- BioXcel Therapeutics Announces SERENITY ... Source: Bioxcel Therapeutics Aug 26, 2025 @ 8:00 PM BioXcel Therapeutics To Announce Topline Results f... Source: Bioxcel Therapeutics, Inc. Aug 18, 2025 @ 11:00 AM BioXcel Therapeutics Announces Positive FDA Pre-sN... Source: Bioxcel Therapeutics Financials   TTM Q2 2025 Q1 2025 Basic EPS $-26.49 $-2.45 $-1.5 Diluted EPS $-26.49 $-2.45 $-1.5 Revenue $ .87M $ .12M $ .17M Gross Profit $ -1.26M $ .01M $ .15M Net Income / Loss $ -50.95M $ -19.19M $ -7.25M Operating Income / Loss $ -51.74M $ -15.85M $ -10.1M Cost of Revenue $ 2.12M $ .11M $ .01M Net Cash Flow $ M $ M $ M PE Ratio     Splits Feb 10, 2025:   1:16